Medicover Genetics Technology Transfer Platform
In Vitro Diagnostic Tests
Information
Our Technology Transfer Platform utilizes Medicover Genetics’ proprietary technology, bioinformatics, and validated protocols enabling laboratories to set up and deploy high fidelity in-house genetic services. Our performance has been recognized by independent studies for its accuracy and precision.
Our Technology Transfer Platform can combine our VERACITY and VERACITY High Content (HC) NIPT kits with our TarCET kits into an integrated workflow, allowing the combination of multiple discipline assays onto the same sequencing run, resulting in laboratory operational efficiency, and cost optimization.
Our operations are certified under ISO 13485:2016 and ISO 9001:2015 standards and accredited under ISO 15189:2012, College of American Pathologists (CAP) and Clinical Laboratory Improvement Amendments (CLIA) standards, ensuring the highest of quality.
